Today: 26 January 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Meta Platforms (META) Stock on December 9, 2025: AI Pivot, Metaverse Cuts and EU Ad Rules Shape the 2026 Outlook

Meta Platforms (META) Stock on December 9, 2025: AI Pivot, Metaverse Cuts and EU Ad Rules Shape the 2026 Outlook

As of December 9, 2025, Meta Platforms, Inc. (NASDAQ: META) is trading around $667 per share, giving the social media and AI giant a market capitalization of roughly $1.68 trillion. Over the past year the stock has traded between $479.80 and $796.25, and is up about 14% year-to-date, modestly outperforming the broader market but lagging some of the other “Magnificent…
9 December 2025
···
Netflix Stock Falls as Warner Bros. Deal Faces Hostile Challenge – What NFLX Investors Need to Know Now

Netflix Stock Falls as Warner Bros. Deal Faces Hostile Challenge – What NFLX Investors Need to Know Now

Netflix, Inc. (NASDAQ: NFLX) stock is under pressure again on December 9, 2025, as Wall Street digests a rare combination of events: a giant, high‑risk media acquisition, a surprise hostile counterbid, fresh analyst downgrades, and a rapidly scaling ads business that’s quietly becoming a second growth engine. As of mid‑day Tuesday, Netflix shares trade around $96.79, down about 3.4% from…
9 December 2025
····
Apple (AAPL) Stock on December 9, 2025: AI Shake‑Up, Fitness+ Expansion and Fresh $350 Price Targets

Apple (AAPL) Stock on December 9, 2025: AI Shake‑Up, Fitness+ Expansion and Fresh $350 Price Targets

Apple Inc. (NASDAQ: AAPL) is trading just below record highs on December 9, 2025, as investors digest a sweeping AI leadership overhaul, a major Apple Fitness+ expansion, and a wave of Wall Street price‑target hikes that now stretch as high as $350 per share. As of early U.S. trading, Apple stock is hovering around $278, roughly 4% under its 52‑week…
9 December 2025
····
Microsoft Stock (MSFT) on December 9, 2025: Canada AI Megainvestment, Chip Shake‑Up and Wall Street’s 2026 Price Targets

Microsoft Stock (MSFT) on December 9, 2025: Canada AI Megainvestment, Chip Shake‑Up and Wall Street’s 2026 Price Targets

Microsoft Corp. (NASDAQ: MSFT) is back in the spotlight on December 9, 2025, as investors digest a fresh multibillion‑dollar AI infrastructure pledge in Canada, a potential shake‑up in its AI chip supply chain, short‑term issues with Copilot availability in Europe, and a wall of bullish—but demanding—analyst forecasts. Below is a detailed, news‑driven look at MSFT as of December 9, 2025,…
9 December 2025
····
Broadcom (AVGO) Stock Near Record Highs as OpenAI Mega‑Deal and Dec. 11 Earnings Put AI Trade Back in Focus

Broadcom (AVGO) Stock Near Record Highs as OpenAI Mega‑Deal and Dec. 11 Earnings Put AI Trade Back in Focus

Broadcom Inc. (NASDAQ: AVGO) is back in the market spotlight. The semiconductor and infrastructure‑software giant is trading around $400 a share, near fresh all‑time highs, after a wave of bullish analyst calls, a multi‑year 10‑gigawatt AI accelerator deal with OpenAI, and growing anticipation for its fourth‑quarter and full‑year 2025 earnings on December 11. MarketBeat Below is a deep dive into…
9 December 2025
····
Tesla Stock (TSLA) Today: Morgan Stanley Downgrade, China Sales Twist and 2026 AI Bet – December 9, 2025

Tesla Stock (TSLA) Today: Morgan Stanley Downgrade, China Sales Twist and 2026 AI Bet – December 9, 2025

Tesla, Inc. (NASDAQ: TSLA) is back in the spotlight as Wall Street recalibrates its expectations for the world’s most valuable automaker‑turned‑AI company. As of midday Tuesday, December 9, 2025, Tesla shares trade around $439.58, giving the company a market capitalization of roughly $1.46 trillion. MarketBeat The stock is up single digits this year after a volatile run and sits about…
9 December 2025
····
Nvidia (NVDA) Stock Jumps as Trump Clears China AI Chip Sales – Latest Price, News and 2026–2030 Forecasts

Nvidia (NVDA) Stock Jumps as Trump Clears China AI Chip Sales – Latest Price, News and 2026–2030 Forecasts

Published: December 9, 2025 Key Takeaways Nvidia Stock Today: Price, Performance and Market Context As of around 12:53 UTC on Tuesday, December 9, 2025, Nvidia shares trade near $185.55, up about 1.7% on the day, according to real‑time quote data. Trefis notes the stock recently hit a high of about $207.04 in late October, meaning NVDA now sits roughly 10%…
9 December 2025
····
AppLovin (APP) Stock After Hours on December 8, 2025 – What to Know Before the December 9 Market Open

AppLovin (APP) Stock After Hours on December 8, 2025 – What to Know Before the December 9 Market Open

AppLovin Corporation (NASDAQ: APP) heads into Tuesday’s session near record territory after a modest pullback and a flurry of fresh analyst, technical and valuation headlines on Monday, December 8, 2025. Here’s a deep dive into how APP traded after the bell and what investors should watch before the U.S. stock market opens on December 9. Note: All figures are as…
9 December 2025
···
Costco (COST) Stock After Hours on December 8, 2025: Tariff Lawsuit, Dividend Odds and What to Watch Before the December 9 Open

Costco (COST) Stock After Hours on December 8, 2025: Tariff Lawsuit, Dividend Odds and What to Watch Before the December 9 Open

Costco Wholesale Corporation (NASDAQ: COST) ended Monday, December 8, 2025, with another modest pullback as investors weighed strong sales, a high valuation, a new lawsuit against the Trump administration over tariffs, and growing chatter about whether a special dividend is likely when the company reports earnings on December 11. The stock slipped during the regular session and barely budged after…
9 December 2025
···
Home Depot (HD) Stock After the Bell on December 8, 2025: Downgrade Fallout and Investor Day Preview for the December 9 Open

Home Depot (HD) Stock After the Bell on December 8, 2025: Downgrade Fallout and Investor Day Preview for the December 9 Open

Home Depot, Inc. (NYSE: HD) finished Monday’s session under pressure and stayed subdued after the bell as Wall Street digested a fresh price‑target cut, mixed analyst signals, and lingering worries about the health of the U.S. consumer ahead of the company’s Investor & Analyst Conference on Tuesday, December 9, 2025. Below is a detailed look at how Home Depot traded…
9 December 2025
····
Walmart (WMT) Stock After Hours on December 8, 2025: NYSE Delisting, Nasdaq Switch and What to Watch Before the December 9 Open

Walmart (WMT) Stock After Hours on December 8, 2025: NYSE Delisting, Nasdaq Switch and What to Watch Before the December 9 Open

Published: December 9, 2025 – All figures as of the U.S. close on December 8 unless otherwise noted. 1. Quick Take: How Walmart Stock Looks Going Into December 9 Walmart Inc. (ticker: WMT) heads into Tuesday’s session with three big storylines converging at once: On Monday, Walmart closed at about $113.56, down roughly 1.3% on the day, after trading between…
9 December 2025
····
Wave Life Sciences (WVE) Soars 147% on Obesity Drug Breakthrough and $250M Offering: What to Know Before the December 9 Open

Wave Life Sciences (WVE) Soars 147% on Obesity Drug Breakthrough and $250M Offering: What to Know Before the December 9 Open

Wave Life Sciences Ltd. (NASDAQ: WVE) just delivered one of the wildest biotech moves of 2025. On Monday, December 8, 2025, the stock rocketed after the company reported positive Phase 1 obesity drug data for WVE‑007 and simultaneously launched a $250 million equity offering. With the next U.S. trading session set to open on Tuesday, December 9, investors are trying…
9 December 2025
···
1 … 695 696 697 698 699 … 827

Stock Market Today

  • Sarepta Therapeutics Faces Biotech Headwinds Amid Potential Upside
    January 26, 2026, 8:22 AM EST. Sarepta Therapeutics (NASDAQ: SRPT) operates in rare disease biotech, focusing on Duchenne muscular dystrophy treatments with drugs like EXONDYS 51. Its stock trades near $21.13, after a wide 52-week range of $11.93 to $119.02, reflecting sector volatility. Despite a 14.5% revenue decline and negative earnings per share (-2.83), the forward price-to-earnings ratio of 6.77 indicates some expected profitability. Analyst ratings are mixed; 7 buy, 14 hold, and 5 sell, with an average target price slightly below current levels. Technical indicators show the stock close to oversold levels, suggesting a possible entry point for investors. Sarepta's future hinges on its drug pipeline and strategic partnerships as it navigates financial pressures common in biotech firms investing heavily in research and development.
Go toTop